Engaging and Activating Cancer Survivors in Genetic Services Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

391

Participants

Timeline

Start Date

August 16, 2021

Primary Completion Date

March 5, 2025

Study Completion Date

December 31, 2025

Conditions
Cancer
Interventions
BEHAVIORAL

Remote Telegenetic Counseling by Phone

Participants will receive standard of care pre-test and disclosure genetic counseling with a genetic counselor by Telephone.

BEHAVIORAL

Remote Telegenetic Counseling by Videoconferencing

Participants will receive standard of care pre-test and disclosure genetic counseling with a genetic counselor using Videoconferencing Technology.

BEHAVIORAL

Usual Care Arm

Participants in the usual care arm will receive usual care services depending on which referral method they choose and if they initiate services. After a 6 month status survey, if they have not had genetic services through usual care they will be offered services and re-randomized to ARM A/ARM B.

Trial Locations (3)

19104

University of Pennsylvania, Philadelphia

60637

University of Chicago Medical Center, Chicago

38105-3678

St Jude Children's Research Hospital, Memphis

All Listed Sponsors
collaborator

University of Pennsylvania

OTHER

collaborator

St. Jude Children's Research Hospital

OTHER

collaborator

Fox Chase Cancer Center

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

University of Chicago

OTHER